 Nidhya Navanandan
Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 10 | 2023 | 2158 | 2.940 |
Why?
| | Anti-Asthmatic Agents | 3 | 2022 | 343 | 1.780 |
Why?
| | Pneumonia | 7 | 2023 | 592 | 1.500 |
Why?
| | Respiratory Tract Infections | 3 | 2023 | 331 | 0.990 |
Why?
| | Community-Acquired Infections | 5 | 2023 | 143 | 0.980 |
Why?
| | Virus Diseases | 2 | 2023 | 198 | 0.860 |
Why?
| | Emergency Service, Hospital | 9 | 2022 | 1865 | 0.830 |
Why?
| | Airway Resistance | 1 | 2020 | 33 | 0.750 |
Why?
| | Oscillometry | 1 | 2020 | 34 | 0.750 |
Why?
| | Child | 21 | 2023 | 19129 | 0.730 |
Why?
| | Staphylococcus aureus | 1 | 2023 | 394 | 0.720 |
Why?
| | Glucocorticoids | 2 | 2020 | 545 | 0.640 |
Why?
| | Patient Discharge Summaries | 1 | 2017 | 10 | 0.600 |
Why?
| | Biomedical Research | 1 | 2023 | 612 | 0.600 |
Why?
| | Physicians, Primary Care | 1 | 2020 | 222 | 0.580 |
Why?
| | Positive-Pressure Respiration | 1 | 2017 | 70 | 0.580 |
Why?
| | Pulmonary Embolism | 1 | 2019 | 183 | 0.580 |
Why?
| | Health Literacy | 1 | 2017 | 169 | 0.490 |
Why?
| | Prednisone | 3 | 2020 | 235 | 0.490 |
Why?
| | Physicians | 1 | 2022 | 794 | 0.480 |
Why?
| | Emergency Medical Services | 2 | 2021 | 589 | 0.470 |
Why?
| | Patient Readmission | 1 | 2017 | 634 | 0.400 |
Why?
| | Caregivers | 1 | 2017 | 709 | 0.370 |
Why?
| | Acute Disease | 3 | 2022 | 940 | 0.370 |
Why?
| | Prednisolone | 2 | 2020 | 76 | 0.370 |
Why?
| | Child, Preschool | 7 | 2022 | 9491 | 0.330 |
Why?
| | Humans | 22 | 2023 | 118974 | 0.330 |
Why?
| | Adrenal Cortex Hormones | 2 | 2023 | 521 | 0.320 |
Why?
| | Dexamethasone | 2 | 2020 | 320 | 0.320 |
Why?
| | Prospective Studies | 8 | 2023 | 6471 | 0.310 |
Why?
| | Hospitalization | 4 | 2022 | 1785 | 0.270 |
Why?
| | Severity of Illness Index | 3 | 2022 | 2674 | 0.230 |
Why?
| | Enterotoxins | 1 | 2023 | 86 | 0.230 |
Why?
| | Quality of Life | 3 | 2023 | 2366 | 0.220 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2023 | 61 | 0.220 |
Why?
| | Delphi Technique | 1 | 2023 | 164 | 0.210 |
Why?
| | Viruses | 1 | 2023 | 96 | 0.210 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2023 | 99 | 0.210 |
Why?
| | Magnesium | 1 | 2022 | 150 | 0.200 |
Why?
| | Male | 9 | 2023 | 57801 | 0.200 |
Why?
| | Administration, Intravenous | 1 | 2022 | 136 | 0.200 |
Why?
| | Dyspnea | 1 | 2023 | 201 | 0.200 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 4708 | 0.190 |
Why?
| | Consensus | 1 | 2023 | 534 | 0.190 |
Why?
| | Allergens | 1 | 2023 | 424 | 0.180 |
Why?
| | Bronchodilator Agents | 2 | 2021 | 253 | 0.170 |
Why?
| | Self Report | 1 | 2022 | 699 | 0.160 |
Why?
| | Thrombectomy | 1 | 2019 | 60 | 0.160 |
Why?
| | Vena Cava Filters | 1 | 2019 | 50 | 0.160 |
Why?
| | Administration, Oral | 1 | 2020 | 756 | 0.160 |
Why?
| | Risk Factors | 3 | 2022 | 9000 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2020 | 749 | 0.150 |
Why?
| | Ipratropium | 1 | 2017 | 5 | 0.150 |
Why?
| | Influenza, Human | 1 | 2023 | 554 | 0.150 |
Why?
| | Nebulizers and Vaporizers | 1 | 2017 | 82 | 0.140 |
Why?
| | Albuterol | 1 | 2017 | 104 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 119 | 0.140 |
Why?
| | Sepsis | 1 | 2022 | 531 | 0.140 |
Why?
| | Single-Blind Method | 1 | 2017 | 269 | 0.140 |
Why?
| | Female | 7 | 2022 | 61565 | 0.130 |
Why?
| | Patient Discharge | 2 | 2022 | 796 | 0.130 |
Why?
| | Phenotype | 1 | 2023 | 3003 | 0.130 |
Why?
| | Prognosis | 1 | 2023 | 3443 | 0.130 |
Why?
| | Health Surveys | 1 | 2017 | 454 | 0.130 |
Why?
| | Anticoagulants | 1 | 2019 | 559 | 0.120 |
Why?
| | Infant | 4 | 2023 | 8293 | 0.120 |
Why?
| | Disease Progression | 1 | 2021 | 2490 | 0.120 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1166 | 0.120 |
Why?
| | Ambulatory Care | 1 | 2017 | 482 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2017 | 610 | 0.110 |
Why?
| | Biomarkers | 1 | 2023 | 3588 | 0.110 |
Why?
| | Primary Health Care | 1 | 2020 | 1560 | 0.090 |
Why?
| | Pediatrics | 1 | 2017 | 985 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1185 | 0.080 |
Why?
| | Retrospective Studies | 2 | 2021 | 12978 | 0.070 |
Why?
| | Adult | 2 | 2020 | 31512 | 0.070 |
Why?
| | Adolescent | 2 | 2022 | 18480 | 0.070 |
Why?
| | Patient Acuity | 1 | 2022 | 37 | 0.060 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1510 | 0.060 |
Why?
| | Young Adult | 1 | 2017 | 10793 | 0.050 |
Why?
| | Fever | 1 | 2022 | 283 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2022 | 5255 | 0.050 |
Why?
| | Aftercare | 1 | 2022 | 194 | 0.050 |
Why?
| | ROC Curve | 1 | 2022 | 473 | 0.050 |
Why?
| | Fatigue | 1 | 2022 | 297 | 0.050 |
Why?
| | Epinephrine | 1 | 2021 | 167 | 0.040 |
Why?
| | Middle Aged | 1 | 2020 | 27617 | 0.040 |
Why?
| | Odds Ratio | 1 | 2022 | 996 | 0.040 |
Why?
| | Hospitals, Pediatric | 1 | 2022 | 505 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2022 | 4596 | 0.030 |
Why?
| | Cohort Studies | 1 | 2022 | 5116 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 4552 | 0.030 |
Why?
| | United States | 1 | 2022 | 12555 | 0.020 |
Why?
|
|
Navanandan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|